Publicação
COVID-19 Vaccine Effectiveness among older adults
| datacite.subject.fos | Ciências Médicas::Ciências da Saúde | |
| datacite.subject.sdg | 03:Saúde de Qualidade | |
| dc.contributor.author | Laniece Delaunay, Charlotte | |
| dc.contributor.author | Mateo-Urdiales, Alberto | |
| dc.contributor.author | Pérez-Gimeno, Gloria | |
| dc.contributor.author | O'Reilly, Karen | |
| dc.contributor.author | Uras, Marina | |
| dc.contributor.author | Erdwiens, Annika | |
| dc.contributor.author | Mlinaric, Ivan | |
| dc.contributor.author | Túri, Gergo | |
| dc.contributor.author | Martínez-Baz, Iván | |
| dc.contributor.author | Meijer, Adam | |
| dc.contributor.author | Rodrigues, Ana Paula | |
| dc.contributor.author | Lazar, Mihaela | |
| dc.contributor.author | Latorre-Margalef, Neus | |
| dc.contributor.author | Lucaccioni, Héloïse | |
| dc.contributor.author | Verdasca, Nuno | |
| dc.contributor.author | Bella, Antonino | |
| dc.contributor.author | Rafael de la Cruz Lopez, Maria Angeles | |
| dc.contributor.author | Kelly, Eva | |
| dc.contributor.author | Enouf, Vincent | |
| dc.contributor.author | Tolksdorf, Kristin | |
| dc.contributor.author | Puzelli, Simona | |
| dc.contributor.author | Ibáñez Pérez, Ana Carmen | |
| dc.contributor.author | Fitzgerald, Margaret | |
| dc.contributor.author | Masse, Shirley | |
| dc.contributor.author | Oh, Djin-Ye | |
| dc.contributor.author | Kaczmarek, Marlena | |
| dc.contributor.author | Bacci, Sabrina | |
| dc.contributor.author | Kissling, Esther | |
| dc.contributor.author | VEBIS Primary Care Vaccine Effectiveness Group | |
| dc.date.accessioned | 2026-10-07T09:44:58Z | |
| dc.date.available | 2026-10-07T09:44:58Z | |
| dc.date.issued | 2026-06-15 | |
| dc.description | Research Letter | |
| dc.description | The VEBIS Primary Care Vaccine Effectiveness Group Investigators and Coordinators: João Almeida Santos, Licínia Gomes, Ausenda Machado, Raquel Guiomar (INSA). | |
| dc.description.abstract | Introduction: From September to November 2025, many European countries launched COVID-19 vaccination campaigns, when SARS-CoV-2 incidence was decreasing after a period of high circulation.1 These campaigns targeted specific groups, including older adults (ie, individuals aged at or above a minimum threshold that varied from age 60 to 70 years across countries). We estimated the effectiveness of COVID-19 vaccines administered during these seasonal vaccination campaigns in Europe against medically attended, symptomatic SARS-CoV-2 infection among older adults, from September 29, 2025, to January 10, 2026. | eng |
| dc.description.abstract | Plain language summary: This case-control study examines COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection among older adults in Europe. | eng |
| dc.description.sponsorship | This study was funded by the framework contract ECDC/2021/019 from the European Centre for Disease Prevention and Control (ECDC). | |
| dc.identifier.citation | JAMA Netw Open. 2026 Jun 1;9(6):e2619040. doi: 10.1001/jamanetworkopen.2026.19040 | |
| dc.identifier.doi | 10.1001/jamanetworkopen.2026.19040 | |
| dc.identifier.eissn | 2574-3805 | |
| dc.identifier.pmid | 42295762 | |
| dc.identifier.uri | http://hdl.handle.net/10400.18/11379 | |
| dc.language.iso | eng | |
| dc.peerreviewed | yes | |
| dc.publisher | American Medical Association | |
| dc.relation.hasversion | https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2850251 | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject | COVID‐19 | |
| dc.subject | SARS‐CoV‐2 | |
| dc.subject | Vaccine Effectiveness | |
| dc.subject | VEBIS | |
| dc.subject | Cuidados de Saúde | |
| dc.subject | Infecções Respiratórias | |
| dc.title | COVID-19 Vaccine Effectiveness among older adults | eng |
| dc.type | journal article | |
| dcterms.references | https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2850251?guestAccessKey=1b34668e-afe8-4888-aa3d-dd05b3b83eff&__cf_chl_f_tk=OQuctnnjC6okyGxr3Uzy7vT4kXyg3lLMVvsSTbN4xh0-1783436457-1.0.1.1-2pCUpvAXL0gBZUifcIEfOUymVel234yDZoAEG9HNMwY#supplemental-tab | |
| dspace.entity.type | Publication | |
| oaire.citation.issue | 6 | |
| oaire.citation.startPage | 19040 | |
| oaire.citation.title | JAMA Network Open | |
| oaire.citation.volume | 9 | |
| oaire.version | http://purl.org/coar/version/c_970fb48d4fbd8a85 |
Ficheiros
Principais
1 - 1 de 1
Miniatura indisponível
- Nome:
- Delaunay_2026_COVID-19 Vaccine Effectiveness Among Older Adults.pdf
- Tamanho:
- 406.36 KB
- Formato:
- Adobe Portable Document Format
Licença
1 - 1 de 1
Miniatura indisponível
- Nome:
- license.txt
- Tamanho:
- 4.03 KB
- Formato:
- Item-specific license agreed upon to submission
- Descrição:
